These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 30880653

  • 1. Rituximab as a Preemptive Treatment to Prevent Recurrence of Primary Focal Segmental Glomerulosclerosis: A Novel Approach.
    El Khashab S, El Khashab O, El Ghoneimy M, AbdelRassoul MA.
    Exp Clin Transplant; 2019 Jun; 17(3):326-329. PubMed ID: 30880653
    [Abstract] [Full Text] [Related]

  • 2. Primary Focal Segmental Glomerulosclerosis Recurrence After Pediatric Renal Transplantation.
    Baskın E, Avcı B, Gülleroğlu K, Akdur A, Moray G, Haberal M.
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):55-60. PubMed ID: 35384808
    [Abstract] [Full Text] [Related]

  • 3. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A, Piecha G, Więcek A.
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [Abstract] [Full Text] [Related]

  • 4. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
    Unagami K, Kawanishi K, Shimizu T, Kanzawa T, Toki D, Okumi M, Omoto K, Horita S, Koike J, Honda K, Nagashima Y, Ishida H, Tanabe K, Nitta K.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
    [Abstract] [Full Text] [Related]

  • 5. Clinical Outcomes of Prophylactic and Therapeutic Plasmapheresis in Adult Deceased-Donor Kidney Transplant Recipients With Primary Focal Segmental Glomerulosclerosis.
    Campise M, Favi E, Messa P.
    Exp Clin Transplant; 2019 Aug; 17(4):461-469. PubMed ID: 30570457
    [Abstract] [Full Text] [Related]

  • 6. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S, Vlachopanos G, Georgalis A, Liapis G, Skalioti C, Zavos G, Boletis JN.
    Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
    [Abstract] [Full Text] [Related]

  • 7. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange.
    Fadel FI, Bazaraa HM, Abdel Mawla MA, Salah DM.
    Ital J Pediatr; 2021 Dec 14; 47(1):236. PubMed ID: 34906202
    [Abstract] [Full Text] [Related]

  • 8. Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.
    Alasfar S, Matar D, Montgomery RA, Desai N, Lonze B, Vujjini V, Estrella MM, Manllo Dieck J, Khneizer G, Sever S, Reiser J, Alachkar N.
    Transplantation; 2018 Mar 14; 102(3):e115-e120. PubMed ID: 29189487
    [Abstract] [Full Text] [Related]

  • 9. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.
    Kandus A, Ponikvar R, Buturović-Ponikvar J, Bren AF, Oblak M, Mlinšek G, Kmetec A, Arnol M.
    Ther Apher Dial; 2013 Aug 14; 17(4):438-43. PubMed ID: 23931886
    [Abstract] [Full Text] [Related]

  • 10. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A, Kaori S, Takei T, Nitta K.
    CEN Case Rep; 2020 Aug 14; 9(3):195-199. PubMed ID: 31997159
    [Abstract] [Full Text] [Related]

  • 11. Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab.
    Koutroutsos K, Charif R, Moran L, Moss J, Cook T, Roufosse C, Pusey C, Taube D, Loucaidou M.
    Clin Exp Nephrol; 2019 May 14; 23(5):700-709. PubMed ID: 30637591
    [Abstract] [Full Text] [Related]

  • 12. Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients.
    Iguchi Y, Tanabe K, Yagisawa T, Fuchinoue S, Kawai T, Kawaguchi H, Takahashi K, Ito K, Toma H, Agishi T, Ota K.
    Ther Apher; 1997 May 14; 1(2):191-4. PubMed ID: 10225770
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
    Angeletti A, Bin S, Magnasco A, Bruschi M, Cravedi P, Ghiggeri GM.
    Am J Transplant; 2024 Apr 14; 24(4):688-692. PubMed ID: 38101474
    [Abstract] [Full Text] [Related]

  • 14. Clinical Course of Nonresponders With Recurrent Focal Segmental Glomerulosclerosis After Pediatric Kidney Transplantation: A Retrospective Multicenter Study.
    Ban H, Miura K, Ando T, Shirai Y, Kaneko N, Ishizuka K, Hotta K, Hattori M.
    Pediatr Transplant; 2024 Aug 14; 28(5):e14809. PubMed ID: 38853135
    [Abstract] [Full Text] [Related]

  • 15. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
    Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.
    BMC Nephrol; 2018 Dec 17; 19(1):361. PubMed ID: 30558559
    [Abstract] [Full Text] [Related]

  • 16. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H, Bonzi JY, Noble J, Terrec F, Motte L, Imerzoukene F, Bugnazet M, Giovannini D, Janbon B, Malvezzi P, Rostaing L, Jouve T.
    Blood Purif; 2020 Dec 17; 49(3):322-333. PubMed ID: 31913143
    [Abstract] [Full Text] [Related]

  • 17. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.
    Am J Nephrol; 2017 Dec 17; 46(2):108-113. PubMed ID: 28700988
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis.
    Staeck O, Halleck F, Budde K, Khadzhynov D.
    Transplant Proc; 2017 Dec 17; 49(10):2256-2259. PubMed ID: 29198656
    [Abstract] [Full Text] [Related]

  • 19. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
    Dęborska-Materkowska D, Kozińska-Przybył O, Mikaszewska-Sokolewicz M, Durlik M.
    Transplant Proc; 2014 Oct 17; 46(8):2908-11. PubMed ID: 25380948
    [Abstract] [Full Text] [Related]

  • 20. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
    Hansrivijit P, Ghahramani N.
    Int Urol Nephrol; 2020 Jul 17; 52(7):1377-1387. PubMed ID: 32306197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.